Literature DB >> 34738636

Deep learning identifies inflamed fat as a risk factor for lymph node metastasis in early colorectal cancer.

Scarlet Brockmoeller1, Amelie Echle2, Narmin Ghaffari Laleh2, Susanne Eiholm3, Marie Louise Malmstrøm4, Tine Plato Kuhlmann5, Katarina Levic6, Heike Irmgard Grabsch1,7, Nicholas P West1, Oliver Lester Saldanha2, Katerina Kouvidi1, Aurora Bono1, Lara R Heij7,8,9, Titus J Brinker10, Ismayil Gögenür11,12, Philip Quirke1, Jakob Nikolas Kather1,2,13.   

Abstract

The spread of early-stage (T1 and T2) adenocarcinomas to locoregional lymph nodes is a key event in disease progression of colorectal cancer (CRC). The cellular mechanisms behind this event are not completely understood and existing predictive biomarkers are imperfect. Here, we used an end-to-end deep learning algorithm to identify risk factors for lymph node metastasis (LNM) status in digitized histopathology slides of the primary CRC and its surrounding tissue. In two large population-based cohorts, we show that this system can predict the presence of more than one LNM in pT2 CRC patients with an area under the receiver operating curve (AUROC) of 0.733 (0.67-0.758) and patients with any LNM with an AUROC of 0.711 (0.597-0.797). Similarly, in pT1 CRC patients, the presence of more than one LNM or any LNM was predictable with an AUROC of 0.733 (0.644-0.778) and 0.567 (0.542-0.597), respectively. Based on these findings, we used the deep learning system to guide human pathology experts towards highly predictive regions for LNM in the whole slide images. This hybrid human observer and deep learning approach identified inflamed adipose tissue as the highest predictive feature for LNM presence. Our study is a first proof of concept that artificial intelligence (AI) systems may be able to discover potentially new biological mechanisms in cancer progression. Our deep learning algorithm is publicly available and can be used for biomarker discovery in any disease setting.
© 2021 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. © 2021 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  AI; artificial intelligence; deep learning; digital pathology; early colorectal cancer; inflamed adipose tissue; metastasis; new predictive biomarker; pT1 and pT2 bowel cancer; prediction LNM

Mesh:

Year:  2021        PMID: 34738636     DOI: 10.1002/path.5831

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  5 in total

1.  Utility of artificial intelligence with deep learning of hematoxylin and eosin-stained whole slide images to predict lymph node metastasis in T1 colorectal cancer using endoscopically resected specimens; prediction of lymph node metastasis in T1 colorectal cancer.

Authors:  Joo Hye Song; Yiyu Hong; Eun Ran Kim; Seok-Hyung Kim; Insuk Sohn
Journal:  J Gastroenterol       Date:  2022-07-08       Impact factor: 6.772

Review 2.  Deep Learning on Histopathological Images for Colorectal Cancer Diagnosis: A Systematic Review.

Authors:  Athena Davri; Effrosyni Birbas; Theofilos Kanavos; Georgios Ntritsos; Nikolaos Giannakeas; Alexandros T Tzallas; Anna Batistatou
Journal:  Diagnostics (Basel)       Date:  2022-03-29

3.  Spatial heterogeneity and organization of tumor mutation burden with immune infiltrates within tumors based on whole slide images correlated with patient survival in bladder cancer.

Authors:  Hongming Xu; Jean René Clemenceau; Sunho Park; Jinhwan Choi; Sung Hak Lee; Tae Hyun Hwang
Journal:  J Pathol Inform       Date:  2022-05-21

Review 4.  Digital Pathology and Artificial Intelligence Applications in Pathology.

Authors:  Heounjeong Go
Journal:  Brain Tumor Res Treat       Date:  2022-04

5.  Adversarial attacks and adversarial robustness in computational pathology.

Authors:  Narmin Ghaffari Laleh; Daniel Truhn; Gregory Patrick Veldhuizen; Tianyu Han; Marko van Treeck; Roman D Buelow; Rupert Langer; Bastian Dislich; Peter Boor; Volkmar Schulz; Jakob Nikolas Kather
Journal:  Nat Commun       Date:  2022-09-29       Impact factor: 17.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.